CYBREX AMIKACIN— 510(k) K802669

Substantially Equivalent

Abbott Laboratories

FDA 510(k) clearance K802669 for CYBREX AMIKACIN, Substantially Equivalent on 1980-11-12. Applicant: Abbott Laboratories. Device class: 2.

Clearance details

Applicant: Abbott Laboratories
Product code: Code KLQ
Device class: Class 2
Regulation: 21 CFR 862.3035
Advisory panel: Clinical Toxicology
Date received: 1980-10-27
Decision date: 1980-11-12
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Abbott Park, IL, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code KLQ

K052815 — QMS AMIKACIN REAGENTS2005-11-01
K033884 — RANDOX AMIKACIN2004-06-09
K955570 — INNOFLUOR AMIKACIN ASSAY SYSTEM1996-02-09
K903100 — INNOFLUOR (TM) AMIKACIN REAGENT SET1990-08-09
K894517 — FPR AMIKACIN KIT1989-09-28

More clearances from Abbott Laboratories

K252424 — Anti-HCV Next2026-04-28
K243500 — ARCHITECT iGentamicin2025-07-09
K243168 — Alinity i Rubella IgG2025-06-20
K243283 — Alinity h-series System2025-02-20
K233932 — Alinity i Toxo IgM2024-08-30

Data sourced from openFDA. This site is unofficial and independent of the FDA.